Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.1K Sell
108
-63
-37% -$21.6K ﹤0.01% 409
2026
Q1
$60.2K Sell
171
-66
-28% -$23.5K ﹤0.01% 343
2025
Q4
$77.6K Buy
237
+12
+5% +$3.81K 0.01% 312
2025
Q3
$63.5K Sell
225
-221
-50% -$64.1K 0.01% 293
2025
Q2
$125K Sell
446
-26
-6% -$7.37K 0.01% 226
2025
Q1
$147K Buy
+472
New +$139K 0.01% 235

Other funds holding AMGN

N.E.W. Advisory Services's AMGN Position: Q2 2026 in Review

N.E.W. Advisory Services reduced its Amgen (AMGN) stake by 37% in Q2 2026, selling an estimated $21.6K and leaving 108 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #409.

N.E.W. Advisory Services first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $147K in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • N.E.W. Advisory Services held 108 shares of Amgen worth $39.1K as of Q2 2026.
  • N.E.W. Advisory Services sold 63 Amgen shares in Q2 2026, an estimated $21.6K.
  • Amgen made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #409 holding.
  • N.E.W. Advisory Services first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • N.E.W. Advisory Services's Amgen position peaked at $147K in Q1 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.